Bicycle Therapeutics (BCYC)
8.49
-0.48 (-5.35%)
At close: Mar 31, 2025, 3:59 PM
8.53
0.52%
After-hours: Mar 31, 2025, 06:17 PM EDT
Bicycle Therapeutics Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Cash & Equivalents | 879.52M | 526.42M | 339.15M | 438.68M | 135.99M | 92.12M | 63.38M | 67.66M | 9.4M |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 11.07M | 5.79M | 8.46M | 3.45M | 1.82M | 1.7M | 3.04M | 1.13M | 30K |
| Receivables | 35.65M | 24.04M | 21.21M | 11.91M | 14.63M | 7.14M | 11.31M | 3M | 1.37M |
| Inventory | n/a | n/a | 1.00 | n/a | n/a | 1.00 | n/a | n/a | 1.00 |
| Other Current Assets | 13.43M | 11.41M | 9.02M | 7.96M | 5.1M | 4.88M | 2.08M | 848K | 1.88M |
| Total Current Assets | 928.61M | 561.87M | 369.38M | 458.56M | 155.72M | 104.15M | 76.77M | 71.51M | 11.29M |
| Property-Plant & Equipment | 17.19M | 27.68M | 32.77M | 17.79M | 3.61M | 4.35M | 1.82M | 1.36M | 519K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 28.26M | 33.48M | 41.23M | 21.24M | 5.43M | 6.05M | 4.86M | 2.49M | 549K |
| Total Assets | 956.87M | 595.34M | 410.61M | 479.79M | 161.15M | 110.19M | 81.63M | 74M | 11.83M |
| Account Payables | 15.79M | 13.05M | 6.47M | 2.72M | 1.36M | 1.95M | 1.89M | 2.06M | 1.88M |
| Deferred Revenue | 10.19M | 24.98M | 20.42M | 19.27M | 10.13M | 728K | 10K | 3.98M | n/a |
| Short-Term Debt | n/a | 4.88M | 3.13M | 2.38M | 844K | 640K | n/a | n/a | n/a |
| Other Current Liabilities | 41.25M | 26.63M | 23.33M | 11.86M | 10.79M | 5.5M | 7.02M | 3.31M | 1.92M |
| Total Current Liabilities | 67.23M | 69.54M | 53.34M | 36.24M | 23.13M | 8.82M | 8.93M | 9.45M | 3.81M |
| Long-Term Debt | 3.99M | 40.08M | 41.2M | 41.95M | 14.93M | 1.25M | n/a | n/a | n/a |
| Other Long-Term Liabilities | 92.59M | 4.58M | 3.83M | 3.28M | 2.61M | 2M | 127.9M | 101.25M | n/a |
| Total Long-Term Liabilities | 96.58M | 154.88M | 86.48M | 97.3M | 42.56M | 8.18M | 142.52M | 111.73M | n/a |
| Total Liabilities | 163.81M | 224.41M | 139.83M | 133.54M | 65.69M | 17M | 151.45M | 121.19M | 3.81M |
| Total Debt | 3.99M | 44.96M | 44.33M | 44.34M | 15.78M | 1.89M | n/a | n/a | n/a |
| Common Stock | 890K | 550K | 387K | 384K | 266K | 227K | 10K | 5K | 3K |
| Retained Earnings | -680.79M | -511.76M | -331.1M | -218.38M | -151.56M | -100.55M | -69.94M | -48.1M | -31.84M |
| Comprehensive Income | 119K | -1.3M | 387K | -3.39M | -3.19M | -1.53M | -1.75M | 69K | -2.29M |
| Shareholders Equity | 793.06M | 370.93M | 270.78M | 346.25M | 95.46M | 93.2M | -69.83M | -47.18M | 8.02M |
| Total Investments | n/a | 547K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |